A detailed history of Capital Group Private Client Services, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capital Group Private Client Services, Inc. holds 471,138 shares of BMY stock, worth $27.7 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
471,138
Previous 510,827 7.77%
Holding current value
$27.7 Million
Previous $21.2 Million 14.93%
% of portfolio
0.25%
Previous 0.22%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$39.66 - $51.75 $1.57 Million - $2.05 Million
-39,689 Reduced 7.77%
471,138 $24.4 Million
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $79.7 Million - $105 Million
-1,979,846 Reduced 79.49%
510,827 $21.2 Million
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $83.5 Million - $94.7 Million
1,741,288 Added 232.36%
2,490,673 $135 Million
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $52.7 Million - $62.8 Million
-1,086,355 Reduced 59.18%
749,385 $38.5 Million
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $1.09 Million - $1.22 Million
18,863 Added 1.04%
1,835,740 $107 Million
Q2 2023

Aug 11, 2023

BUY
$63.71 - $70.74 $11.9 Million - $13.3 Million
187,472 Added 11.51%
1,816,877 $116 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $12 Million - $13.6 Million
182,967 Added 12.65%
1,629,405 $113 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $2.21 Million - $2.62 Million
32,291 Added 2.28%
1,446,438 $104 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $89,363 - $52.8 Million
687,414 Added 94.59%
1,414,147 $101 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $4.79 Million - $5.28 Million
65,956 Added 9.98%
726,733 $56 Million
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $40.6 Million - $48.7 Million
660,777 New
660,777 $48.3 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Capital Group Private Client Services, Inc. Portfolio

Follow Capital Group Private Client Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Group Private Client Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital Group Private Client Services, Inc. with notifications on news.